Caption Management’s G1 Therapeutics GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-320,800
Closed -$731K – 1662
2024
Q2
$731K Buy
320,800
+141,400
+79% +$540K 0.01% 729
2024
Q1
$775K Buy
+179,400
New +$625K 0.01% 797
2020
Q1
– Sell
-150,000
Closed -$3.96M – 1133
2019
Q4
$3.96M Hold
150,000
– – 0.13% 214
2019
Q3
$3.42M Buy
+150,000
New +$4.73M 0.18% 153

Caption Management's GTHX Position: Q3 2024 in Review

Caption Management sold out of G1 Therapeutics (GTHX) in Q3 2024, closing a stake of 185,505 shares — an estimated $423K sold.

Caption Management first reported a position in GTHX in Q4 2019 and held it in 3 quarters. The position peaked at $748K in Q4 2019. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Caption Management reported no remaining G1 Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 185,505 G1 Therapeutics shares in Q3 2024, an estimated $423K.
  • Caption Management first reported a position in G1 Therapeutics in Q4 2019 and held it in 3 quarters.
  • Caption Management's G1 Therapeutics position peaked at $748K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.